Properties of Poly(3-hydroxybutyrate-co-3-hydroxyvalerate)/Polycaprolactone Polymer Mixtures Reinforced by Cellulose Nanocrystals: Experimental and Simulation Studies

Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (P(3HB-co-3HV))/Bacterial Cellulose (BC) Biocomposites for Potential Use in Biomedical Applications

The aim of this study was to obtain biocomposites consisting of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV), bacterial cellulose (BC) and α-tocopherol by a melt processing technique for potential use in biomedical applications. The melt processing and roughness of biocomposites were evaluated and compared to sample without BC. The degradation rate of PHBV/BC biocomposites was measured in phosphate buffer saline (PBS) by determining the mass variation and evidencing of thermal and structural changes by differential scanning calorimetry (DSC) and attenuated total reflectance-Fourier transformed infrared spectrometry (ATR-FTIR). The cell viability, cell morphology, cell cycle distribution and total collagen content were investigated on murine NCTC fibroblasts. Overall, the adding of BC to polyester matrix led to an adequate melt processing of biocomposites and increased surface roughness and cytocompatibility, allowing the cells to secrete the extracellular matrix (collagen) and stimulate cell proliferation. Results showed that the PHBV/BC biocomposites were favorable for long-term degradation and could be used for the design of medical devices with controlled degradability.

Effects of Endic Anhydride Grafted PPC on the Properties of PHBV Blends

Poly(β-hydroxybutyrate-co-β-hydroxyvalerate) (PHBV) was modified with endic anhydride grafted poly(propylene carbonate) (EA-PPC), and then PHBV/EA-PPC composite polymers were prepared by melt blending under the catalysis of stannous octoate (Sn(Oct)₂). The blends were characterized by an electronic universal testing machine, cantilever impact testing machine, and differential scanning calorimeter (DSC), as well as dynamic mechanical analysis (DMA) and field emission scanning electron microscopy (FESEM). Effects of the amount of Sn(Oct)₂ on the mechanical properties, thermal properties, and morphology of the blends were discussed. The results showed that the addition of Sn(Oct)₂ promoted the transesterification reaction between PHBV and EA-PPC, and the compatibility between PHBV and PPC was greatly improved. When the amount of Sn(Oct)₂ was 3 wt%, the impact strength and elongation at break of the PHBV/EA-PPC blend increased from 3.7 kJ/m² and 4.1% to 5.9 kJ/m² and 387.5%, respectively, and there was no significant decrease in tensile strength. Additionally, four esterification reaction mechanisms for PHBV/EA-PPC blends were proposed.

A review on contemporary nanomaterial-based therapeutics for the treatment of diabetic foot ulcers (DFUs) with special reference to the Indian scenario

Diabetes mellitus (DM) is a predominant chronic metabolic syndrome, resulting in various complications and high mortality associated with diabetic foot ulcers (DFUs). Approximately 15-30% of diabetic patients suffer from DFUs, which is expected to increase annually. The major challenges in treating DFUs are associated with wound infections, alterations to inflammatory responses, angiogenesis and lack of extracellular matrix (ECM) components. Furthermore, the lack of targeted therapy and efficient wound dressings for diabetic wounds often results in extended hospitalization and limb amputations. Hence, it is essential to develop and improve DFU-specific therapies. Nanomaterial-based innovative approaches have tremendous potential for preventing and treating wound infections of bacterial origin. They have greater benefits compared to traditional wound dressing approaches. In this approach, the physiochemical features of nanomaterials allow researchers to employ different methods for diabetic wound healing applications. In this review, the status and prevalence of diabetes mellitus (DM) and amputations due to DFUs in India, the pathophysiology of DFUs and their complications are discussed. Additionally, nanomaterial-based approaches such as the use of nanoemulsions, nanoparticles, nanoliposomes and nanofibers for the treatment of DFUs are studied. Besides, emerging therapeutics such as bioengineered skin substitutes and nanomaterial-based innovative approaches such as antibacterial hyperthermia therapy and gene therapy for the treatment of DFUs are highlighted. The present nanomaterial-based techniques provide a strong base for future therapeutic approaches for skin regeneration strategies in the treatment of diabetic wounds.